Showing results (5741-5750 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|May 27, 2022
Controversies in the Pharmacotherapy of Adolescent DepressionGabriele MasiCurrent Pharmaceutical Design|May 27, 2022
HNF1A-AS1: A Tumor-associated Long Non-coding RNAYuling Liu, Fangnan Zhao, Fangshun Tan, et al.Current Pharmaceutical Design|May 16, 2022
A Systematic Review of Nonclinical Studies on the Effect of Curcumin in Chemotherapy- induced CardiotoxicityMaryam Armandeh, Behnaz Bameri, Mahedeh Samadi, et al.Current Pharmaceutical Design|May 17, 2022
MEG8: An Indispensable Long Non-coding RNA in Multiple CancersZhuoying Du, Fangshun Tan, Jinlan Chen, et al.Current Pharmaceutical Design|May 19, 2022
Evolving Era of "Sponges": Nanosponges as a Versatile Nanocarrier for the Effective Skin Delivery of DrugsPrashansha Mullick, Aswathi R Hegde, Divya Gopalan, et al.Current Pharmaceutical Design|May 19, 2022
Docosahexaenoic Acid Ester of Phloridzin Reduces Inflammation and Insulin Resistance via AMPKJingqing Chen, Zhenlong Wu, Jin Wang, et al.Current Pharmaceutical Design|November 17, 2017
Seizures and Antiepileptic Drugs: From Pathophysiology to Clinical PracticeNihan Carcak, Cigdem OzkaraCurrent Pharmaceutical Design|October 10, 2017
Statins and inflammation in cardiovascular diseaseGeorgia Vogiatzi, Evangelos Oikonomou, Gerasimos Siasos, et al.Current Pharmaceutical Design|October 10, 2017
Level V Metastasis, a Novel Predicative Factor for Recurrence in N1b Papillary Thyroid CarcinomaYifeng Wu, Jianjun Li, Xianjiang Wu, et al.Current Pharmaceutical Design|October 8, 2003
Cilostazol as a unique antithrombotic agentJunichi Kambayashi, Yongge Liu, Bing Sun, et al.Pageof 1,008